•  
  •  
  •  
  •  

2025-10-02 06:09:11

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  INE239A01016

Research

  • Q4FY22 Result Update - Nestle India - ICICI Direct
  • Nestle India - Q1CY22 Result Update - Margins yet to bottom out: Accumulate
  • Nestle India - Q1CY22 First Cut - ICICI Direct
  • Q3CY21 Result Update - Nestle India - ICICI Direct
  • Maintain REDUCE on Nestle India - Revenue momentum sustains; miss in margin - HDFC Securities

Stock Report

  • Nestle India Ltd approves stock split
  • Nestle India Ltd declares 2nd interim dividend of Rs. 140
  • NestlĂ© India expand its portfolio launches NestlĂ© a+ Masala Millet
  • Nestle India Ltd gets in principle approval from IPICOL for food processing unit at Mundaamba
  • Nestle India Ltd declares interim dividend of Rs. 27
  • NESTLE India Ltd announces Q4, CY2022 results
  • NESTLE India Ltd recommends final dividend of Rs. 75
  • Nestle India Ltd declares 2nd interim dividend of Rs. 120
  • Nestle India Ltd to acquire Pet Foods Business from Purina PetCare India Private Limited
  • Nestle India Limited - Key Highlights of Q1 CY2022
  • Nestle India appoints Ms Alpana Parida as Independent Non-Executive Director
  • Nestle India Ltd declares interim dividend of Rs. 25
  • Nestle India Ltd recommends final dividend of Rs. 65
  • Nestle India Receives Approval Under Production Linked Scheme
  • Nestle India Ltd Board approves second interim dividend of Rs. 110

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024